The 3,000 mg full serving greatly exceeds a typical standalone range for a product aimed at relaxation, stress, or sleep support. Oral GABA targets an inhibitory pathway, but its ability to reach the brain reliably remains uncertain.
Powder delivery allows flexible portioning and avoids tablet disintegration. The single-active design is easy to assess and avoids unrelated ingredients.
The supply and serving cost provide good practical value. The formula is better suited to situational calming than to broad mood support or circadian sleep timing.
thumb_upPros
Flexible powder portioning
Focused active-ingredient list
Forty-two full servings
thumb_downCons
Full scoop is excessively high
Greater risk of dose-related side effects
Does not address circadian timing
warningWarnings
GABA may cause drowsiness; do not drive or operate machinery until its effects are known.
Alcohol, sleep medicines, sedating antihistamines, and other sedatives may intensify impaired alertness.
GABA may lower blood pressure in some users; monitor for dizziness when using blood-pressure medicine.
scienceNutrient quality
50
Lower impact
Powder delivery allows reduction of the portion, but ordinary GABA remains absorption-limited does not overcome the main uncertainty about how much ordinary GABA reaches the brain. The full serving greatly exceeds the preferred standalone range.
scienceIngredient transparency
81
Highest impact
The GABA amount is clearly disclosed. Excipients and daily directions are absent from the supplied data, which leaves some label details uncertain.
thumb_upCustomer satisfaction
59
Moderate impact
The aggregate satisfaction average is favorable, though no detailed feedback is supplied. The small volume limits confidence in the aggregate satisfaction signal.
workspace_premiumValue for money
46
Lower impact
A low price cannot fully offset an unnecessarily aggressive full serving. The price is moderate, but the oversized full serving reduces practical value.
B
Goal FitA+
Strength of SupportC
CoverageA
Formula Quality
GABA · 3000 mg
Gamma-aminobutyric acid directly targets inhibitory signaling and relaxation at a high disclosed amount. The focused design is transparent and free from competing stimulants.
Evidence for oral gamma-aminobutyric acid crossing into the brain and reliably reducing stress remains limited. The product therefore offers strong dose clarity but uncertain real-world effectiveness.
scienceStudy evidence
SupportiveMixedNo effectAdverse
GABA Supportive star star star star star_border 6 studies
C-
Goal FitD-
Strength of SupportF
CoverageB+
Formula Quality
GABA offers a direct relaxation pathway and the powder format allows flexible portioning. The full scoop, however, supplies far more than the preferred range for this ingredient.
Oral GABA has limited and inconsistent sleep evidence, and the single-active formula does not address circadian timing. A 3,000 mg serving may increase drowsiness, dizziness, or tingling, so lower-dose flexibility is important.
scienceStudy evidence
SupportiveMixedNo effectAdverse
GABA Supportive star star star_border star_border star_border 4 studies
B+
Active Ingredient Quality & BioavailabilityD-
Dose, Safety & Label TransparencyD-
Value
The powder format allows flexible mixing and may support rapid delivery. However, the single-scoop GABA amount greatly exceeds the preferred range, which can increase the chance of drowsiness, dizziness, or tingling. The serving cost is moderate, but the excessive dose reduces practical value.
<p>A meaningful amount of fermented branded GABA provides well-defined, focused relaxation support. Compared with the original, the fermented branded source provides clearer source definition; the defined source improves quality confidence, although individual response to oral GABA may still vary.</p>
<p>Branded fermented GABA and a well-targeted amount provide focused relaxation support. Compared with the original, the fermented branded source provides clearer source definition; the defined source improves quality confidence, although individual response to oral GABA may still vary.</p>
<p>Liposomal delivery plus L-theanine creates a technically strong and coherent calming formula. Compared with the original, liposomal delivery and L-theanine provide a broader calming design; the supplied feedback and high serving cost still weaken value confidence.</p>
<p>A substantial GABA amount in flexible liquid form provides highly economical relaxation support. The lower serving cost improves value compared with the original; its lower amount may suit someone seeking a gentler serving, while ordinary oral GABA still has uncertain brain availability.</p>
<p>A clearly disclosed upper-range GABA amount provides focused calming support in a simple formula, but ordinary oral GABA has uncertain access to the brain and human effects vary. The lower serving cost improves value compared with the original; its lower amount may suit someone seeking a gentler serving, while ordinary oral GABA still has uncertain brain availability.</p>
<p>A clearly disclosed well-centered GABA amount provides focused calming support in a simple formula, but ordinary oral GABA has uncertain access to the brain and human effects vary. The lower serving cost improves value compared with the original; its lower amount may suit someone seeking a gentler serving, while ordinary oral GABA still has uncertain brain availability.</p>
<p>The combination of a flexible 750 mg GABA serving and an economical serving creates better practical value than the original. The larger amount may cause drowsiness, especially alongside alcohol or other sedating products.</p>
<p>The combination of clearly disclosed 500 mg GABA and an economical serving creates better practical value than the original. Ordinary oral GABA has uncertain access to the brain, so individual effects may vary.</p>
<p>The combination of clearly disclosed 750 mg GABA and an economical serving creates better practical value than the original. The larger amount may cause drowsiness, especially alongside alcohol or other sedating products.</p>
flagReport alternatives
schoolSources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
Plante DT; Jensen JE; Schoerning L; Winkelman JW · Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2012
Case-control study40 participantsflagSleep Support forscienceGABA